AGNC Investment (NASDAQ:AGNC – Get Free Report) and Selectis Health (OTCMKTS:GBCS – Get Free Report) are both finance companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends and risk.
Insider & Institutional Ownership
38.3% of AGNC Investment shares are held by institutional investors. 0.5% of AGNC Investment shares are held by company insiders. Comparatively, 15.2% of Selectis Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for AGNC Investment and Selectis Health, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
AGNC Investment | 0 | 3 | 5 | 0 | 2.63 |
Selectis Health | 0 | 0 | 0 | 0 | N/A |
Risk & Volatility
AGNC Investment has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Comparatively, Selectis Health has a beta of -0.26, suggesting that its stock price is 126% less volatile than the S&P 500.
Valuation & Earnings
This table compares AGNC Investment and Selectis Health’s revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
AGNC Investment | $2.04 billion | 3.49 | $155.00 million | $0.91 | 10.76 |
Selectis Health | $36.78 million | N/A | -$3.97 million | ($1.30) | -1.15 |
AGNC Investment has higher revenue and earnings than Selectis Health. Selectis Health is trading at a lower price-to-earnings ratio than AGNC Investment, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares AGNC Investment and Selectis Health’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
AGNC Investment | 32.12% | 27.14% | 2.54% |
Selectis Health | -24.65% | -651.76% | -21.33% |
Summary
AGNC Investment beats Selectis Health on 11 of the 12 factors compared between the two stocks.
About AGNC Investment
AGNC Investment Corp., formerly American Capital Agency Corp., is a real estate investment trust. The Company invests in agency residential mortgage-backed securities on a leveraged basis. Its investments consist of residential mortgage pass-through securities and collateralized mortgage obligations (CMOs) for which the principal and interest payments are guaranteed by a government-sponsored enterprise, such as the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac), or by the United States Government agency, such as the Government National Mortgage Association (Ginnie Mae) (collectively, GSEs). Its agency securities include agency residential mortgage-backed securities (Agency RMBS) and to-be-announced forward contracts (TBAs). Its Non-Agency Securities include credit risk transfer securities (CRT), non-agency residential mortgage-backed securities (Non-Agency RMBS) and commercial mortgage-backed securities (CMBS).
About Selectis Health
Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.
Receive News & Ratings for AGNC Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGNC Investment and related companies with MarketBeat.com's FREE daily email newsletter.